Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
Condition(s):Medulloblastoma; Ependymoma; Pineal Region Tumors; Choroid Plexus Tumors; Atypical/Malignant MeningiomaLast Updated:January 26, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Medulloblastoma; Ependymoma; Pineal Region Tumors; Choroid Plexus Tumors; Atypical/Malignant MeningiomaLast Updated:January 26, 2024Recruiting
Condition(s):Central Nervous System Neoplasms; Glioblastoma; Gliosarcoma, Adult; Anaplastic Oligodendroglioma; Anaplastic Astrocytoma; Pilocytic Astrocytoma; Oligodendroglioma; Gliomatosis Cerebri; Pleomorphic Xanthoastrocytoma; Anaplastic Pleomorphic Xanthoastrocytoma; Diffuse Midline Glioma, H3 K27M-Mutant; Ependymoma; Ependymoma, Anaplastic; Medulloblastoma; Teratoid Rhabdoid Tumor; Neuroectodermal Tumors, Primitive; Neuroectodermal Tumors; Anaplastic Meningioma; Atypical Meningioma; Choroid Plexus Neoplasms; Pineal Tumor; Diffuse Astrocytoma; Glial TumorLast Updated:October 26, 2023Recruiting
Condition(s):Glioma; Glioneuronal Tumor; Choroid Plexus Tumor; Pineal Tumors; Germ Cell Tumor; Tumor of the Sellar Region; Diffuse Midline Glioma, H3 K27M-Mutant; Ependymoma; Embryonal Tumor; Pineal Tumor; Hemangiopericytoma; Hemangioblastoma; Melanocytic Tumor of CNSLast Updated:March 30, 2023Recruiting
Condition(s):Atypical Choroid Plexus Papilloma; Choroid Plexus CarcinomaLast Updated:June 22, 2023Recruiting
Condition(s):Brain and Central Nervous System TumorsLast Updated:August 2, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.